4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-22-008278
Options or other derivatives
- Chief Financial Officer acquired 422,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Elefant Dov Chief Financial Officer | 2022-01-25 | Grant or award · Stock option (right to buy) | +422,000 | 422,000 | D | ||
Loading xslF345X03/tm224689-2_4seq1.xml…